Fluorescence-guided versus non-fluorescence-guided resection in high-grade glioma: a systematic review and meta-analysis of survival outcomes

Fluorescence-guided resection (FGR) in high-grade glioma surgeries improves tumor visualization and resection extent. Although resection completeness is well documented, its impact on survival varies across studies due to confounding factors and heterogeneity. We conducted a systematic review and meta-analysis to clarify the relationship between fluorescence guidance and survival, distinguishing unadjusted from adjusted effects. A systematic search of PubMed, Embase, Scopus, and Web of Science found studies comparing FGR and non-FGR in adult high-grade glioma patients. Overall survival (OS) and progression-free survival (PFS) were analyzed separately. Risk of Bias was assessed with ROBINS-I and RoB 2, and evidence certainty with GRADE. Seventeen studies involving a total of 2,937 patients (1,466 who underwent FGR and 1,471 who underwent non-FGR) met the inclusion criteria. In unadjusted analyses, FGR was associated with a statistically significant improvement in overall survival (HR 0.72, 95% CI [0.57–0.91]; I2 47.2%), compared to non-FGR. However, in analyses adjusted for key prognostic variables, this association was diminished and no longer reached statistical significance (aHR 0.63, 95% CI [0.30–1.30]; I2 80.3%). Progression-free survival analyses indicated trends toward benefit, although these were not statistically significant in both unadjusted (HR 0.70, 95% CI [0.26–1.89]; I2 = 57.9%) and adjusted models (aHR 0.86, 95% CI [0.29–2.54]; I2 = 80.3%), with notable heterogeneity observed. Subgroup analyses comparing 5-ALA and white-light surgery yielded similar patterns, with effects attenuated following adjustment. The certainty of evidence ranged from low to very low. FGR initially demonstrated superior survival outcomes in high-grade glioma; however, the significance diminished upon adjustment for confounders. It primarily serves as an adjunct to surgical procedures to facilitate safe and maximal resection rather than directly enhancing survival. Further randomized investigations incorporating molecular stratification are essential to elucidate its influence on long-term survival.

Authors

Institutions

Publication Details

Journal
Neurosurgical Review
Published
2026-04-23
DOI
https://doi.org/10.1007/s10143-026-04297-8
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fluorescence-guided versus non-fluorescence-guided resection in high-grade glioma: a systematic review and meta-analysis of survival outcomes

Alejandro N. Santos, Sai Sanikommu, Bashar Dawoud, Ricardo J. Komotar et al.
Neurosurgical Review
Glioma Diagnosis and Treatment
article

Fluorescence-guided versus non-fluorescence-guided resection in high-grade glioma: a systematic review and meta-analysis of survival outcomes

Alejandro N. Santos, Sai Sanikommu, Bashar Dawoud, Ricardo J. Komotar, Victor M. Lu
article en

Abstract

Fluorescence-guided resection (FGR) in high-grade glioma surgeries improves tumor visualization and resection extent. Although resection completeness is well documented, its impact on survival varies across studies due to confounding factors and heterogeneity. We conducted a systematic review and meta-analysis to clarify the relationship between fluorescence guidance and survival, distinguishing unadjusted from adjusted effects. A systematic search of PubMed, Embase, Scopus, and Web of Science found studies comparing FGR and non-FGR in adult high-grade glioma patients. Overall survival (OS) and progression-free survival (PFS) were analyzed separately. Risk of Bias was assessed with ROBINS-I and RoB 2, and evidence certainty with GRADE. Seventeen studies involving a total of 2,937 patients (1,466 who underwent FGR and 1,471 who underwent non-FGR) met the inclusion criteria. In unadjusted analyses, FGR was associated with a statistically significant improvement in overall survival (HR 0.72, 95% CI [0.57–0.91]; I2 47.2%), compared to non-FGR. However, in analyses adjusted for key prognostic variables, this association was diminished and no longer reached statistical significance (aHR 0.63, 95% CI [0.30–1.30]; I2 80.3%). Progression-free survival analyses indicated trends toward benefit, although these were not statistically significant in both unadjusted (HR 0.70, 95% CI [0.26–1.89]; I2 = 57.9%) and adjusted models (aHR 0.86, 95% CI [0.29–2.54]; I2 = 80.3%), with notable heterogeneity observed. Subgroup analyses comparing 5-ALA and white-light surgery yielded similar patterns, with effects attenuated following adjustment. The certainty of evidence ranged from low to very low. FGR initially demonstrated superior survival outcomes in high-grade glioma; however, the significance diminished upon adjustment for confounders. It primarily serves as an adjunct to surgical procedures to facilitate safe and maximal resection rather than directly enhancing survival. Further randomized investigations incorporating molecular stratification are essential to elucidate its influence on long-term survival.

Neurosurgical ReviewVol. 49(1)
University of Miami (US)
Zero hunger
Openalex Percentile: Top 14%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.